First report of phase 2 study of dasatinib with hyper-CVAD for the frontline treatment of patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia
scientific article
Author/s
author: Hagop Kantarjian, Alessandra Ferrajoli, Stefan Faderl, William G Wierda, Jorge Eduardo Cortes, Susan O'Brien, Farhad Ravandi, Gautam Borthakur, Guillermo Garcia-Manero, Rebecca S Garris, Jeffrey C. Jorgensen, Richard E Champlin, Partow Kebriaei, Jan A Burger
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.